SCHEMBL9828252

SCHEMBL9828252

COc1cc(-c2nnn[nH]2)ccc1CCc1cccc(OCc2ccc3ccccc3n2)c1

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYSLTR1 Q9Y271 7/20 0.51
CYSLTR2 Q9NS75 6/20 0.51
GPBAR1 Q8TDU6 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10420750 0.95 CYSLTR1 (0.56) CYSLTR1CYSLTR2GPBAR1
SCHEMBL9828710 0.92 CYSLTR1 (0.49) CYSLTR1CYSLTR2GPBAR1
SCHEMBL6088537 0.90 CYSLTR1 (0.51) CYSLTR1CYSLTR2GPBAR1
SCHEMBL6090364 0.88 CYSLTR1 (0.50) CYSLTR1CYSLTR2GPBAR1
SCHEMBL6088675 0.88 CYSLTR1 (0.50) CYSLTR1CYSLTR2GPBAR1
SCHEMBL9827514 0.87 CYSLTR1 (0.59) CYSLTR1CYSLTR2GPBAR1
SCHEMBL9829075 0.87 CYSLTR1 (0.49) CYSLTR1CYSLTR2GPBAR1
SCHEMBL9827661 0.86 CYSLTR1 (0.44) CYSLTR1CYSLTR2GPBAR1
SCHEMBL9829921 0.86 CYSLTR1 (0.58) CYSLTR1CYSLTR2GPBAR1
SCHEMBL10422053 0.85 CYSLTR1 (0.51) CYSLTR1CYSLTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5051427-A Antiinflammatory agents and antiallergens RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-09-24 US disclosed
EP-0395697-A4 QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4? 1991-03-13 EP disclosed
EP-0395697-A1 QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4 RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1990-11-07 EP disclosed
WO-1989004303-A1 QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 RORER INTERNATIONAL (OVERSEAS) INC. (US) 1989-05-18 WO disclosed